130 related articles for article (PubMed ID: 32772226)
1. Prognostic impact of anatomical extent of metastatic lymph node on gastric cancer: a propensity score matching study.
Cheng LJ; Zhou WJ; An TL; Wei ZW; Yuan C; Xiao X; Hao TF; Yin SC; Zhang CH; He YL
Clin Transl Oncol; 2021 Apr; 23(4):773-782. PubMed ID: 32772226
[TBL] [Abstract][Full Text] [Related]
2. Anatomical location of metastatic lymph nodes: an indispensable prognostic factor for gastric cancer patients who underwent curative resection.
Zhao B; Zhang J; Zhang J; Chen X; Chen J; Wang Z; Xu H; Huang B
Scand J Gastroenterol; 2018 Feb; 53(2):185-192. PubMed ID: 29228846
[TBL] [Abstract][Full Text] [Related]
3. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis.
Son T; Hyung WJ; Kim JW; Kim HI; An JY; Cheong JH; Choi SH; Noh SH
Ann Surg Oncol; 2014 Mar; 21(3):899-907. PubMed ID: 24276641
[TBL] [Abstract][Full Text] [Related]
4. Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Western Tertiary Center.
Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
Am J Clin Oncol; 2021 Jan; 44(1):1-9. PubMed ID: 33086233
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
[TBL] [Abstract][Full Text] [Related]
6. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH
BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475
[TBL] [Abstract][Full Text] [Related]
8. The value of spleen-preserving lymphadenectomy in total gastrectomy for gastric and esophagogastric junctional adenocarcinomas: A long-term retrospective propensity score match study from a high-volume institution in China.
Liu K; Chen XZ; Zhang YC; Zhang WH; Chen XL; Sun LF; Yang K; Zhang B; Zhou ZG; Hu JK
Surgery; 2021 Feb; 169(2):426-435. PubMed ID: 32950240
[TBL] [Abstract][Full Text] [Related]
9. Impact of skip lymph node metastasis on the prognosis of gastric cancer patients who underwent curative gastrectomy.
Zhao B; Mei D; Zhang J; Luo R; Lu H; Xu H; Huang B
J BUON; 2019; 24(2):693-700. PubMed ID: 31128025
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
Bilici A; Selcukbiricik F
Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery.
Posteraro B; Persiani R; Dall'Armi V; Biondi A; Arzani D; Sicoli F; Bonassi S; D'Ugo D; Ricciardi W; Boccia S
Eur J Surg Oncol; 2014 Mar; 40(3):345-51. PubMed ID: 24268760
[TBL] [Abstract][Full Text] [Related]
12. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
14. Skip lymph node metastasis in gastric cancer: is it skipping or skipped?
Choi YY; An JY; Guner A; Kang DR; Cho I; Kwon IG; Shin HB; Hyung WJ; Noh SH
Gastric Cancer; 2016 Jan; 19(1):206-15. PubMed ID: 25708370
[TBL] [Abstract][Full Text] [Related]
15. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
16. Extra-perigastric Extranodal Metastasis is a Significant Prognostic Factor in Node-Positive Gastric Cancer.
Tonouchi A; Sugano M; Tokunaga M; Sugita S; Watanabe M; Sato R; Kaito A; Akimoto T; Ochiai A; Kinoshita T; Kuwata T
World J Surg; 2019 Oct; 43(10):2499-2505. PubMed ID: 31312947
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics in patients with upper third gastric cancer following radical surgical treatment: A retrospective cohort study.
Ma X; Zhou W; Wang C; Miao W; Liu N; Wang S; Guan S
Medicine (Baltimore); 2018 Nov; 97(45):e13017. PubMed ID: 30407293
[TBL] [Abstract][Full Text] [Related]
19. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
20. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?
Biondi A; D'Ugo D; Cananzi FC; Papa V; Borasi A; Sicoli F; Degiuli M; Doglietto G; Persiani R
Eur J Surg Oncol; 2015 Jun; 41(6):779-86. PubMed ID: 25899981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
